Biomedical subjects

J B Hardy

Publications and source records attributed to J B Hardy.

At least 37 records · Page 2Linked to original sources

PubMed1977

Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum bilirubin concentration.

Neurologic and developmental performance during the first year of life was correlated with maximum neonatal serum bilirubin levels for 27,000 infants in the Collaborative Perinatal Project. The infants were grouped by race and by five birth weight/gestational age categories to control for the effect of these factors on hyperbilirubinemia and developmental outcome. Low mean eight-month motor scores and delayed one-year motor development were associated with serum bilirubin levels in the range of 10 to 14 mg/dl and above. This relationship was strongest for low-birth-weight/short-gestational-period infants. A persistent association of developmental outcome with hyperbilirubinemia was found over and above the variation of maturity within the birth weight/gestational age categories.

Bilirubin↗

PubMed1976

Immediate and long-range effects of maternal viral infection in pregnancy.

A brief description of the pathogenesis and immediate and long-range outcome following certain maternal viral infections in pregnancy has been presented. As evidence has accumulated from the follow-up of infants with specific congenital infections, it is clear that the consequences can be disastrous but not just for the obviously affected neonate - the normal-appearing infant at birth may have problems which appear much later. So-called "silent" congenital infections of the central nervous system may be a more frequent cause of mental retardation and specific learning disorders than we realize.

Body Height↗

PubMed1974

Impaired cellular immunity to rubella virus in congenital rubella.

Specific cell-mediated immunity (CMI) responses to rubella virus were studied in 12 children with documented congenital rubella syndrome employing a (51)Cr lymphocytotoxicity microassay. Hemagglutination inhibition antibody was detected in 11 of the 12 children, with titers ranging from 1:4 to 1:128. CMI to rubella virus was demonstrated in only 3 of the 11 antibody-positive children. The 12th child was negative for both hemagglutination inhibition and CMI. Of the three children with a positive CMI response, two had histories of reinfection with rubella virus. These data suggest that congenital rubella infection produces an impaired CMI response which subsequently may be altered by reinfection with rubella virus. The lack of CMI in the presence of antibody and concurrent excretion of live virus in the child with documented congenital rubella infection suggest a factor to be explored in the pathogenesis of this disease.

Adolescent↗

PubMed1974